Market Tracker

05/25 5:16pm ET

Innoviva Inc (NASDAQ:INVA)

11.62
Delayed Data
As of May 25
 +0.18 / +1.57%
Today’s Change
6.36
Today|||52-Week Range
19.96
+10.25%
Year-to-Date

Today’s Trading

Previous close11.44
Today’s open11.52
Day’s range11.39 - 11.77
Volume516,567
Average volume (3 months)700,313
Market cap$1.3B
Dividend yield8.61%
Data as of 4:00pm ET, 05/25/2016

Growth & Valuation

Earnings growth (last year)+89.33%
Earnings growth (this year)+438.75%
Earnings growth (next 5 years)+3.00%
Revenue growth (last year)+247.57%
P/E ratioNM
Price/Sales17.94
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ACORAcorda Therapeutics ...-0.38-1.38%
ACHNAchillion Pharmaceut...+0.16+1.80%
ALDRAlder Biopharmaceuti...-0.62-2.19%
CLLSCellectis SA+0.19+0.61%
Data as of 4:00pm ET, 05/25/2016

Financials

Next reporting dateJuly 27, 2016
EPS forecast (this quarter)$0.12
Annual revenue (last year)$67.8M
Annual profit (last year)-$18.8M
Net profit margin-27.68%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Michael W. Aguiar
Chief Financial Officer &
Senior Vice President
Eric d'Esparbes
Corporate headquarters
South San Francisco, California

Forecasts